9
Cat No. | Product Name | Synonyms | Targets |
---|---|---|---|
T15782 | Lp-PLA2-IN-1 | Lp-PLA2 inhibitor 1,Lp-PLA2 -IN-1 | Phospholipase |
Lp-PLA2-IN-1 (Lp-PLA2 inhibitor 1) suppresses Lp-PLA2 activity processes for their preparation. Lp-PLA2-IN-1 (Lp-PLA2 inhibitor 1) also inhibits to compositions containing them and to their use in the treatment of diseas... | |||
T79076 | Lp-PLA2-IN-16 | Phospholipase | |
Lp-PLA2-IN-16 (Example 1) is an inhibitor of lipoprotein-associated phospholipase A2 (Lp-PLA2) with potential applications in Alzheimer's disease research [1]. | |||
T79075 | Lp-PLA2-IN-15 | Phospholipase | |
Lp-PLA2-IN-15 (example 2) is an inhibitor of lipoprotein-associated phospholipase A2 (Lp-PLA2) with potential application in Alzheimer's disease research [1]. | |||
T79073 | Lp-PLA2-IN-13 | Phospholipase | |
Lp-PLA2-IN-13 (compound 15), a potent Lp-PLA2 inhibitor, holds potential for research in neurodegenerative-related diseases [1]. | |||
T79010 | Lp-PLA2-IN-12 | Phospholipase | |
Lp-PLA2-IN-12 (compound 19), an Lp-PLA2 inhibitor, is utilized in researching neurodegenerative diseases including Alzheimer's disease (AD), glaucoma, age-related macular degeneration (AMD), and cardiovascular conditions... | |||
T75255L | SB-435495 hydrochloride | ||
SB-435495 hydrochloride is a potent, selective, reversible, non-covalent, and orally active inhibitor of Lp-PLA2, exhibiting an IC50 of 0.06 nM [1] [3]. | |||
T75255L1 | SB-435495 ditartrate | ||
SB-435495 ditartrate is a potent, selective, reversible, non-covalent, and orally active inhibitor of Lp-PLA2, demonstrating an IC50 value of 0.06 nM [1] [3]. | |||
T63192 | Lp-PLA2-IN-10 | ||
Lp-PLA2-IN-10 is a potent inhibitor of lipoprotein-associated phospholipase A2 (Lp-PLA2), formerly known as platelet-activating factor acetylhydrolase (PAF-AH). This enzyme plays a role in the hydrolysis of lipoprotein l... | |||
T79074 | Lp-PLA2-IN-14 | Phospholipase | |
Lp-PLA2-IN-14 (Compound 19), an inhibitor of rhLp-PLA2, exhibits a potent inhibitory effect with a pIC50 value of 8.4. This compound is applicable in research pertaining to neurodegenerative disorders, including Alzheime... |